Ubiquitination and degradation of the ORF34 gene product of equine herpesvirus type 1 (EHV-1) at late times of infection (Q42207095)

18 October 2017

Ubiquitination and degradation of the ORF34 gene product of equine herpesvirus type 1 (EHV-1) at late times of infection (English)

1 reference

18 October 2017

protein ubiquitination

1 reference

3

Nikolaus Osterrieder

1 reference

18 October 2017

Abdelrahman Said

1

1 reference

PubMed ID

25010266

18 October 2017

Armando Damiani

series ordinal

2

1 reference

PubMed ID

25010266

18 October 2017

language of work or name

English

0 references

publication date

29 May 2014

1 reference

18 October 2017

1 reference

18 October 2017

460-461

1 reference

18 October 2017

11-22

1 reference

The early UL3 gene of equine herpesvirus-1 encodes a tegument protein not essential for replication or virulence in the mouse

18 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

The ubiquitin-proteasome system at the crossroads of stress-response and ageing pathways: a handle for skin care?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Isolation of equine herpesvirus 1 from the brain of a horse affected with paresis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Equine herpesvirus type 1 infected cell polypeptides: evidence for immediate early/early/late regulation of viral gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Varicella-zoster virus open reading frame 1 encodes a membrane protein that is dispensable for growth of VZV in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

7 January 2021

The order Herpesvirales

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Proteasomes: machines for all reasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Structural mechanisms underlying posttranslational modification by ubiquitin-like proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

ICP0, a regulator of herpes simplex virus during lytic and latent infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin-associated domain-containing protein to promote protein degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Proteasome degradation: enter the substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

A point mutation in a herpesvirus polymerase determines neuropathogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Regulation of equine herpesvirus type 1 gene expression: characterization of immediate early, early, and late transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Identification and transcriptional analysis of a 3'-coterminal gene cluster containing UL1, UL2, UL3, and UL3.5 open reading frames of bovine herpesvirus-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Identification and characterization of equine herpesvirus type 1 pUL56 and its role in virus-induced downregulation of major histocompatibility complex class I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Phosphorylation of Kaposi's sarcoma-associated herpesvirus processivity factor ORF59 by a viral kinase modulates its ability to associate with RTA and oriLyt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Comparative sequence analysis of the long repeat regions and adjoining parts of the long unique regions in the genomes of herpes simplex viruses types 1 and 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Glycoprotein gIII deletion mutants of pseudorabies virus are impaired in virus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Human herpesvirus 6B induces phosphorylation of p53 in its regulatory domain by a CK2- and p38-independent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Polyubiquitin chains: polymeric protein signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Equine herpesvirus type 1 devoid of gM and gp2 is severely impaired in virus egress but not direct cell-to-cell spread

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Equine herpesvirus type 1 (EHV-1) open reading frame 59 encodes an early protein that is localized to the cytosol and required for efficient virus growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Equine herpesvirus 1 (EHV-1) glycoprotein M: effect of deletions of transmembrane domains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Orthopoxviruses require a functional ubiquitin-proteasome system for productive replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

The DNA sequence of equine herpesvirus-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

The DNA sequence of equine herpesvirus-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Recognition of the polyubiquitin proteolytic signal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Replication of equine herpesvirus type 1 in freshly isolated equine peripheral blood mononuclear cells and changes in susceptibility following mitogen stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

A glycoprotein M-deleted equid herpesvirus 4 is severely impaired in virus egress and cell-to-cell spread.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

Equine herpesviruses 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Herpes simplex virus resistance and sensitivity to phosphonoacetic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2014.05.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2014.05.009

1 reference

18 October 2017

1 reference

PubMed ID

25010266